Mice nibbling at the secrets of NF1

In the April 1st issue of Genes and Development, an international team of scientists lead by Dr. Luis Parada at the University of Texas Southwestern Medical School present an experimental mouse model of a prevalent human genetic disorder. Neuro-fibromatosis type 1 (NF1) is a neurologic disorder that affects 1 in 3,500 people world-wide. People with NF1 develop benign tumors along their peripheral and optic nerves, as well as caf-au-lait skin spots. NF1 is also associated with an increased risk of malignant neurological tumor development and childhood learning disabilities.

NF1 is one of the few diseases for which the underlying molecular mechanism is known. NF1 patients have defects in the NF1 gene, a tumor suppressor that negatively regulates the Ras protein. Ras acts as an intermediate between growth factor receptors on the outside of cells and the enzymatic cascade inside that activates genes required for cell proliferation and growth. NF1 is an essential checkpoint of Ras activity.

Previous attempts to create a mouse strain that lacks the NF1 gene have been unsuccessful because mutant mice die as embryos. However, using an advanced genetic engineering technique, Dr. Parada and his team were able to produce a strain of mice in which the NF1 ablation is restricted to mature neuronal cells only. This conditional NF1 knock-out thereby circumvents the embryonic lethality of a typical NF1 deficiency.

The NF1 deficient mice exhibited defective cerebral cortex development as well as an increased number of neural astrocyte cells. Although neurons of these mice exhibited increased Ras activity, the mice have not developed the tumors associated with NF1. However, NF1 deficient mice display severe learning disabilities and thus might present other clinical features of NF1. This conditional NF1 deficiency model will undoubtedly improve our understanding of the physiological role of NF1 and the progression of this common genetic disease.


Contact: Michele McDonough
Cold Spring Harbor Laboratory

Page: 1

Related biology news :

1. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
2. Genes expose secrets of sex on the side
3. Entrepreneurs to be told how natures secrets can improve business
4. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
5. Researchers uncover secrets of immune systems munitions factory
6. Using statistics to decipher secrets of natural mutation
7. Revealing bizarre deep-sea secrets
8. Access to DNA secrets yields better understanding of genes, possible tool for disease diagnosis
9. U-M scientists use 21st-century technology to probe secrets of M. tuberculosis
10. Seabed secrets in English clay
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:

(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative ... to support testing operations in the fight against the COVID-19 pandemic in Zambia. ...
(Date:6/23/2020)... ... June 23, 2020 , ... Rigaku Corporation ... next event in a series of TOPIQ webinars, which will cover the Transferable ... was developed in response to social distancing measures that resulted in postponements and ...
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem cell ... if the stem cell medicine and pharmaceutical industries have easier access to stem cell ... starting July 5 of this year, Independence Day weekend in the U.S., Asymmetrex is ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company ... Known as MediVet Biologics since its formation in 2016, the company is relaunching ... Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... entered into a strategic partnership whereby Catalent will provide support for the development, ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, ... surgery is only the beginning of a successful study, while protecting and accessing the ... Gien, Global Head of Surgery from Envigo in a live webinar ...
(Date:7/10/2020)... BALTIMORE (PRWEB) , ... July ... ... Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has ... This broader license allows PathSensors to move into the point-of-care diagnostic market, ...
Breaking Biology Technology:
Cached News: